Home example 2 - Pharmamarketeer

marketing

Het Martech18 event in 21 quotes

Dinsdag vond het jaarlijkse Marketing Technology even van Adformatie plaats. Een samenvatting in one-liners.

Adformatie Nieuws

3 x gelezen

technologie

Amsterdam UMC opent hightech medisch trainingscentrum

Op 4 februari opent het Amsterdam Skills Centre (ASC) zijn deuren. Het trainingscentrum biedt medisch specialisten en andere zorgverleners van over de hele wereld een innovatieve leeromgeving met twaalf hightech...

Medicalfacts

3 x gelezen

marketing

Genereer leads met je persoonlijke LinkedIn-profiel

“Leads krijgen door je persoonlijke LinkedIn-profiel? Dat gebeurt niet.” Het is een veelgehoorde uitspraak en tevens één van de grootste misvattingen over het zakelijke social media-platform. LinkedIn is...

marketingfacts.nl

3 x gelezen

overig

EU proposes joint studies to speed acceptance of new medicine

The European Commission proposed on Wednesday joint clinical assessments to determine whether approved new drugs and medical devices offer value for money and should be prescribed for patients within national healthcare...

Reuters

3 x gelezen

wet- en regelgeving

EMA herziet olaratumab

Het Europees Geneesmiddelen Agentschap (EMA) start een herziening van het geneesmiddel olaratumab (Lartruvo) volgend op het advies eerder dit jaar om geen nieuwe patiënten meer te laten starten met het geneesmiddel.

Pharmaceutisch Weekblad

3 x gelezen

overig

Takeda completes construction of new global headquarters in Tokyo

Japan’s biggest pharmaceutical firm Takeda has announced the completion of construction of its new global headquarters in the country’s capital of Tokyo, named inventively as “Takeda Global Headquarters”.

Pharmafile

3 x gelezen

onderzoek

MSD’s Keytruda meets primary endpoint in triple-negative breast cancer

MSD have announced results from its Phase 3, KEYNOTE-522 trial that pathological complete response (pCR) in patients with early triple-negative breast cancer significantly increased from 51.2% in the placebo group to 64...

InPharm.com

3 x gelezen

wet- en regelgeving

Pfizer & Merck’s Inlyta combo becomes first FDA-approved anti-PD-L1 therapy for kidney cancer

The FDA has approved Bavencio (avelumab) in combination with Inlyta (axitinib) for the treatment of advanced renal cell carcinoma (RCC). The decision was announced by the drug’s co-developers Merck KGaA and Pfizer, and...

InPharm.com

3 x gelezen

marketing

Pioneering lifechanging brands

“When your purpose aligns with who you are and is something you genuinely enjoy, you’re not really working a day in your life.” This is how Craig Romanok, president CDMP explained his job to Larry Dobrow, editor-in...

MMM - Medical Marketing and Media

3 x gelezen

farma-industrie

Study finds growing support to allow pharmacists to write prescriptions

Prescribing of medications has traditionally been restricted to physicians, but there is growing support to allow pharmacists to do so as well.

News-Medical.Net

3 x gelezen

Latest articles

Het Martech18 event in 21 quotes

Amsterdam UMC opent hightech medisch trainingscentrum

Genereer leads met je persoonlijke LinkedIn-profiel

EU proposes joint studies to speed acceptance of new medicine

EMA herziet olaratumab

Takeda completes construction of new global headquarters in Tokyo

MSD’s Keytruda meets primary endpoint in triple-negative breast cancer

Pfizer & Merck’s Inlyta combo becomes first FDA-approved anti-PD-L1 therapy for kidney cancer

Pioneering lifechanging brands

Study finds growing support to allow pharmacists to write prescriptions

Wekelijkse highlights per e-mail

Algemene informatie